ALNY vs CXDO · P/E 76, rev $1.29B vs P/E 54, rev $68.2M
Alnylam Pharmaceuticals Inc (ALNY) versus Crexendo Inc (CXDO) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Crexendo Inc (CXDO) is a telecom services company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported CXDO revenue for 2025-12-31 was $68.2M. Net income was $5.1M. CXDO currently screens at market cap $245.4M and trailing P/E 54.1.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. CXDO currently screens at market cap $245.4M and trailing P/E 54.1.
Not investment advice. Open the ALNY and CXDO stock pages for the full models.
Not investment advice.